[Utility of hCG dosage in the management of gestational trophoblastic diseases]
Alban Gildas Comlan Zohoun1, Karl Hounmenou1, Samira El Idrissi Mechtani1
1Laboratoire de biochimie-toxicologie, Hôpital militaire d'instruction Mohammed V, Rabat, Maroc.
Insights
Monitoring human chorionic gonadotropin (hCG) is crucial for diagnosing and managing gestational trophoblastic diseases (GTD). Rigorous hCG level monitoring during treatment and follow-up significantly improves patient outcomes and disease prognosis.
Area of Science:
- Reproductive Endocrinology
- Gynecologic Oncology
- Clinical Chemistry
Background:
- Human chorionic gonadotropin (hCG) measurement is fundamental for the diagnosis, treatment, and follow-up of gestational trophoblastic diseases (GTD).
- Gestational trophoblastic diseases represent a spectrum of pregnancy-related tumors requiring precise management strategies.
Purpose of the Study:
- To evaluate the contribution of hCG measurement in the diagnosis, treatment, and follow-up of GTD.
- To assess the prognostic value of hCG monitoring in patients with GTD.
Main Methods:
- A prospective cohort study was conducted over 18 months.
- 35 patients diagnosed with GTD were included.
- hCG levels were measured using electrochemiluminescence.
Main Results:
- The overall frequency of GTD was 0.33 per 100 childbirths.
- 26 patients presented with abnormal hCG levels (>200,000 UI/mL).
- 73.5% of patients treated with uterine aspiration experienced favorable outcomes with normalized hCG levels within 3-13 weeks.
- 9 patients had unfavorable outcomes, including relapse or hCG stagnation.
Conclusions:
- Rigorous monitoring of hCG levels is essential for improving the prognosis of GTD.
- Consistent hCG surveillance aids in early detection of relapse and guides treatment adjustments.
- Effective management of GTD relies on precise and timely hCG quantification.
Abstract:
Measurement of hCG remains today central for diagnosis, treatment and follow-up of gestational trophoblastic diseases (GTD). In order to evaluate this contribution, we conducted a prospective cohort study in the Service of high-risk pregnancy of Rabat Maternity Les Orangers and the Laboratory of Rabat Military Teaching Hospital Mohammed V over a period of eighteen months. 35 patients were included. The hCG assay was determined by electrochemiluminescence. The general frequency of the GTD is of 0.33/100 childbirth. The average age of our patients was 30.5 years. 26 patients had hCG level abnormal and higher than 200 000 UI/mL when diagnosed with GTD; 34 patients had simple endo-uterine aspiration and 1 a chemotherapy. Among 34 patients, 25 (73.5%) had a favourable evolution characterized by normal hCG level within 3 to 13 weeks and complete remission. Serum hCG remained stable and negative in all these patients with a follow-up of 18 months. 9 patients had unfavourable evolution characterized by reaxent after negativation or stagnation of hCG levels. A rigorous monitoring of hCG levels during treatment and follow-up is essential to improve forecast of these diseases.
Related Concept Videos
Ovarian Cycle
Gonadal and Placental Hormones
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair...
Diabetes Mellitus: Type 2 and Gestational
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...


